drugset
drugset / Trial / NCT01324752

A Drug-Drug Interaction Study of Losartan and PA21

NCT01324752 ↗

Phase 1 Completed 36 enrolled Vifor Pharma
RandomizedCrossoverOpen-labelBasic science

Summary

The purpose of this study is to determine if Losartan potassium is affected by PA21.

Timeline

Start
2011-03
Primary completion
2011-06
Completion
2011-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Losartan Other / unclassified 100 mg —
Subject PA21 Unknown 15 g —

Indications

No indication recorded.